Press Releases

Date Title  
Toggle Summary West Announces Fall Investor Conference Schedule
EXTON, Pa. , Aug. 25, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September.
West Announces Fall Investor Conference Schedule
EXTON, Pa. , Aug. 25, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September.
Toggle Summary West Announces Second-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017.
West Announces Second-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017.
Toggle Summary West Announces Increase to Quarterly Dividend
West to Host Second-Quarter 2017 Conference Call EXTON, Pa. , July 20, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has approved a fourth-quarter
West Announces Increase to Quarterly Dividend
West to Host Second-Quarter 2017 Conference Call EXTON, Pa. , July 20, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has approved a fourth-quarter
Toggle Summary West Elects New Director to the Board
EXTON, Pa. , June 1, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Deborah Keller as its newest member. With the addition of Ms. Keller, West's Board of Directors increases in size to 11 directors. Ms.
West Elects New Director to the Board
EXTON, Pa. , June 1, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Deborah Keller as its newest member. With the addition of Ms. Keller, West's Board of Directors increases in size to 11 directors. Ms.
Toggle Summary West to Present on Biologics Trends at InnoPack Pharma Confex
Presentation caps week-long series of educational seminars throughout India sharing scientific insights and best practices in drug containment and delivery for injectable biologics EXTON, Pa. , May 30, 2017 /PRNewswire/ -- (Booth #B-3) -- West Pharmaceutical Services, Inc.
West to Present on Biologics Trends at InnoPack Pharma Confex
Presentation caps week-long series of educational seminars throughout India sharing scientific insights and best practices in drug containment and delivery for injectable biologics EXTON, Pa. , May 30, 2017 /PRNewswire/ -- (Booth #B-3) -- West Pharmaceutical Services, Inc.
Toggle Summary West Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2, 2017 to shareholders of record as of July 19, 2017 .
West Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2, 2017 to shareholders of record as of July 19, 2017 .
Toggle Summary West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings
EXTON, Pa. , May 3, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that Fran DeGrazio , Vice President Scientific Affairs and Technical Services, and Diane Paskiet , Director,
West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings
EXTON, Pa. , May 3, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that Fran DeGrazio , Vice President Scientific Affairs and Technical Services, and Diane Paskiet , Director,
Toggle Summary West Announces First-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017.  First-Quarter 2017 Highlights
West Announces First-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017.  First-Quarter 2017 Highlights
Toggle Summary West to Host First-Quarter 2017 Conference Call
EXTON, Pa. , April 13, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before the market opens on Thursday, April 27, 2017 ,
West to Host First-Quarter 2017 Conference Call
EXTON, Pa. , April 13, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before the market opens on Thursday, April 27, 2017 ,
Toggle Summary West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 16, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017.  Executive
West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 16, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017.  Executive
Toggle Summary West to Host Fourth-Quarter and Full-Year 2016 Conference Call
EXTON, Pa. , Feb. 2, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2016 financial results before the market opens on Thursday,
West to Host Fourth-Quarter and Full-Year 2016 Conference Call
EXTON, Pa. , Feb. 2, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2016 financial results before the market opens on Thursday,
Toggle Summary West Introduces LyoSeal® Instant Sealing Solution and NovaGuard® SA Pro Safety System at Pharmapack Europe
Scientific and educational sessions to feature West's innovation and regulatory expertise EXTON, Pa. , Feb. 1, 2017 /PRNewswire/ -- Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today introduced two new
West Introduces LyoSeal® Instant Sealing Solution and NovaGuard® SA Pro Safety System at Pharmapack Europe
Scientific and educational sessions to feature West's innovation and regulatory expertise EXTON, Pa. , Feb. 1, 2017 /PRNewswire/ -- Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today introduced two new
Toggle Summary West to Present at J.P. Morgan Healthcare Conference
EXTON, Pa. , Dec. 28, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of the Company's business at the 35 th Annual J.P. Morgan Healthcare Conference , San Francisco, CA , at 3:30 p.m.
West to Present at J.P. Morgan Healthcare Conference
EXTON, Pa. , Dec. 28, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of the Company's business at the 35 th Annual J.P. Morgan Healthcare Conference , San Francisco, CA , at 3:30 p.m.
Toggle Summary West Pharmaceutical Services' Karen Flynn Receives Silver Stevie® Award in 2016 Stevie Awards for Women in Business
Flynn recognized in the Female Executive of the Year category for her instrumental role in developing and executing West's market-led, long-term strategic plan EXTON, Pa. , Dec. 20, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
West Pharmaceutical Services' Karen Flynn Receives Silver Stevie® Award in 2016 Stevie Awards for Women in Business
Flynn recognized in the Female Executive of the Year category for her instrumental role in developing and executing West's market-led, long-term strategic plan EXTON, Pa. , Dec. 20, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
Toggle Summary West Receives Global Industry Recognitions for Innovative Contributions to Pharmaceutical Packaging and Drug Delivery
Company honored with 2016 India Pharma Award and Irish Medtech Excellence Award; West's SmartDose® platform takes second place in Medicine Maker Innovation Awards EXTON, Pa. , Dec. 15, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
West Receives Global Industry Recognitions for Innovative Contributions to Pharmaceutical Packaging and Drug Delivery
Company honored with 2016 India Pharma Award and Irish Medtech Excellence Award; West's SmartDose® platform takes second place in Medicine Maker Innovation Awards EXTON, Pa. , Dec. 15, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
Toggle Summary West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Dec. 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 , to shareholders of record as of January 18,
West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Dec. 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 , to shareholders of record as of January 18,
Toggle Summary West Announces Expanded Contract Manufacturing Capabilities in Ireland
Adds to Growing Manufacturing Footprint in Ireland DUBLIN , Nov. 29, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract
West Announces Expanded Contract Manufacturing Capabilities in Ireland
Adds to Growing Manufacturing Footprint in Ireland DUBLIN , Nov. 29, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract
Toggle Summary West Announces Third Quarter 2016 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 27, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for
West Announces Third Quarter 2016 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 27, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for
Toggle Summary West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices
Two co-presentations with Amgen highlight West's approach to delivering innovative drug delivery solutions for its customers HUNTINGTON BEACH, Calif. , Oct. 17, 2016 /PRNewswire/ --  (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices
Two co-presentations with Amgen highlight West's approach to delivering innovative drug delivery solutions for its customers HUNTINGTON BEACH, Calif. , Oct. 17, 2016 /PRNewswire/ --  (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
Toggle Summary West to Host Third Quarter 2016 Conference Call
EXTON, Pa. , Oct. 13, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before the market opens on Thursday, October 27,
West to Host Third Quarter 2016 Conference Call
EXTON, Pa. , Oct. 13, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before the market opens on Thursday, October 27,
Toggle Summary West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain
EXTON, Pa. , Sept. 26, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice President, Global Operations and Supply Chain,
West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain
EXTON, Pa. , Sept. 26, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice President, Global Operations and Supply Chain,
Toggle Summary West Elects New Director and Announces Increase to Quarterly Dividend
EXTON, Pa. , Sept. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy following the retirement of Anthony Welters .    Mr. Pucci, 54, is Chief Executive Officer of ArQule, Inc.
West Elects New Director and Announces Increase to Quarterly Dividend
EXTON, Pa. , Sept. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy following the retirement of Anthony Welters .    Mr. Pucci, 54, is Chief Executive Officer of ArQule, Inc.
Toggle Summary West to Present at Three Healthcare Conferences in September
EXTON, Pa. , Sept. 2, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at three investor conferences in September.  Management will present at the Baird 2016 Global Healthcare Conference, New York,
West to Present at Three Healthcare Conferences in September
EXTON, Pa. , Sept. 2, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at three investor conferences in September.  Management will present at the Baird 2016 Global Healthcare Conference, New York,
Toggle Summary West Announces Second Quarter 2016 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016.  Second Quarter 2016 Highlights
West Announces Second Quarter 2016 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016.  Second Quarter 2016 Highlights
Toggle Summary West to Host Second Quarter 2016 Conference Call
EXTON, Pa. , July 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second quarter 2016 financial results before the market opens on Thursday, July 28, 2016 , and
West to Host Second Quarter 2016 Conference Call
EXTON, Pa. , July 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second quarter 2016 financial results before the market opens on Thursday, July 28, 2016 , and
Toggle Summary West's SmartDose® Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System
On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) EXTON, Pa. , July 11, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the U.S.
West's SmartDose® Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System
On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) EXTON, Pa. , July 11, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the U.S.
Toggle Summary West Announces Quarterly Dividend
EXTON, Pa. , July 5, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0.12 per share. The dividend will be paid on August 3, 2016 , to shareholders of record as of July 20, 2016
West Announces Quarterly Dividend
EXTON, Pa. , July 5, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0.12 per share. The dividend will be paid on August 3, 2016 , to shareholders of record as of July 20, 2016
Toggle Summary West Introduces 1-3mL NovaPure® Plunger for Higher Volume Injections
New, high-quality plungers launched at the 2016 BIO International Convention EXTON, Pa. , June 7, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure®
West Introduces 1-3mL NovaPure® Plunger for Higher Volume Injections
New, high-quality plungers launched at the 2016 BIO International Convention EXTON, Pa. , June 7, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure®
Toggle Summary West to Present at Investor Conference in June
EXTON, Pa. , June 1, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY , on Wednesday, June 8, 2016 at 11:30 a.m. EDT .
West to Present at Investor Conference in June
EXTON, Pa. , June 1, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY , on Wednesday, June 8, 2016 at 11:30 a.m. EDT .
Toggle Summary West to Present at Two Investor Conferences in May
EXTON, Pa. , May 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care
West to Present at Two Investor Conferences in May
EXTON, Pa. , May 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care
Toggle Summary West Announces First Quarter 2016 Results
- Reports Quarterly Sales of $362 Million, Constant-Currency Sales Growth of 10.5% and Adjusted Diluted EPS of $0.53. - Raises Lower-end of Full-year 2016 Sales and Adjusted EPS Guidance Ranges. - Conference Call Scheduled for 9 a.m. EDT Today. EXTON, Pa.
West Announces First Quarter 2016 Results
- Reports Quarterly Sales of $362 Million, Constant-Currency Sales Growth of 10.5% and Adjusted Diluted EPS of $0.53. - Raises Lower-end of Full-year 2016 Sales and Adjusted EPS Guidance Ranges. - Conference Call Scheduled for 9 a.m. EDT Today. EXTON, Pa.
Toggle Summary West Makes Investment in NanoPass Technologies
EXTON, Pa. , April 25, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. This investment will provide West with access to NanoPass'
West Makes Investment in NanoPass Technologies
EXTON, Pa. , April 25, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. This investment will provide West with access to NanoPass'
Toggle Summary West to Host First Quarter 2016 Conference Call
EXTON, Pa. , April 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, April 28, 2016 ,
West to Host First Quarter 2016 Conference Call
EXTON, Pa. , April 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, April 28, 2016 ,
Toggle Summary West Announces Quarterly Dividend
EXTON, Pa. , March 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share. The dividend will be paid on May 4, 2016 , to shareholders of record as of April 20, 2016
West Announces Quarterly Dividend
EXTON, Pa. , March 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share. The dividend will be paid on May 4, 2016 , to shareholders of record as of April 20, 2016
Toggle Summary West Appoints Eric Resnick to Chief Technology Officer
John Paproski to Retire After 36 Years of Service EXTON, Pa. , March 1, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric Resnick has been appointed to serve as Vice President and
West Appoints Eric Resnick to Chief Technology Officer
John Paproski to Retire After 36 Years of Service EXTON, Pa. , March 1, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric Resnick has been appointed to serve as Vice President and
Toggle Summary West to Host Analyst and Investor Day
EXTON, Pa. , Feb. 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company will host an Analyst and Investor Day on Thursday, March 10, 2016 , from 8:30 a.m. to 12 p.m.
West to Host Analyst and Investor Day
EXTON, Pa. , Feb. 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company will host an Analyst and Investor Day on Thursday, March 10, 2016 , from 8:30 a.m. to 12 p.m.
Toggle Summary West Announces Fourth Quarter and Full-Year 2015 Results
Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47 -- Annual Sales of $1.4 Billion Generated Adjusted Diluted EPS of $1.83 in 2015 -- Reaffirms 2016 Guidance for 6% to 8% Growth in Net Sales at Constant Currency -- Provides Full-Year 2016 Adjusted Diluted EPS Guidance in
West Announces Fourth Quarter and Full-Year 2015 Results
Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47 -- Annual Sales of $1.4 Billion Generated Adjusted Diluted EPS of $1.83 in 2015 -- Reaffirms 2016 Guidance for 6% to 8% Growth in Net Sales at Constant Currency -- Provides Full-Year 2016 Adjusted Diluted EPS Guidance in
Toggle Summary West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen
High-performance containment system selected by top biotech company EXTON, Pa. , Feb. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that global biotechnology leader Amgen Inc.
West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen
High-performance containment system selected by top biotech company EXTON, Pa. , Feb. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that global biotechnology leader Amgen Inc.
Toggle Summary West to Host Fourth Quarter and Full Year 2015 Conference Call
EXTON, PA -- ( Marketwired ) -- 02/11/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2015 financial results before the market opens on Thursday, February 18, 2016 , and will follow with a conference call to discuss the results
West to Host Fourth Quarter and Full Year 2015 Conference Call
EXTON, PA -- ( Marketwired ) -- 02/11/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2015 financial results before the market opens on Thursday, February 18, 2016 , and will follow with a conference call to discuss the results
Toggle Summary West to Present at LEERINK Conference
EXTON, PA -- ( Marketwired ) -- 02/03/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at the LEERINK Partners 5 th Annual Global Healthcare Conference, New York, NY at 10:40 a.m.
West to Present at LEERINK Conference
EXTON, PA -- ( Marketwired ) -- 02/03/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at the LEERINK Partners 5 th Annual Global Healthcare Conference, New York, NY at 10:40 a.m.